157 related articles for article (PubMed ID: 17125247)
1. Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors.
Ikegashira K; Oka T; Hirashima S; Noji S; Yamanaka H; Hara Y; Adachi T; Tsuruha J; Doi S; Hase Y; Noguchi T; Ando I; Ogura N; Ikeda S; Hashimoto H
J Med Chem; 2006 Nov; 49(24):6950-3. PubMed ID: 17125247
[TBL] [Abstract][Full Text] [Related]
2. Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
Gopalsamy A; Lim K; Ciszewski G; Park K; Ellingboe JW; Bloom J; Insaf S; Upeslacis J; Mansour TS; Krishnamurthy G; Damarla M; Pyatski Y; Ho D; Howe AY; Orlowski M; Feld B; O'Connell J
J Med Chem; 2004 Dec; 47(26):6603-8. PubMed ID: 15588095
[TBL] [Abstract][Full Text] [Related]
3. Identification of anthranilic acid derivatives as a novel class of allosteric inhibitors of hepatitis C NS5B polymerase.
Nittoli T; Curran K; Insaf S; DiGrandi M; Orlowski M; Chopra R; Agarwal A; Howe AY; Prashad A; Floyd MB; Johnson B; Sutherland A; Wheless K; Feld B; O'Connell J; Mansour TS; Bloom J
J Med Chem; 2007 May; 50(9):2108-16. PubMed ID: 17402724
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase.
Chen KX; Vibulbhan B; Yang W; Sannigrahi M; Velazquez F; Chan TY; Venkatraman S; Anilkumar GN; Zeng Q; Bennet F; Jiang Y; Lesburg CA; Duca J; Pinto P; Gavalas S; Huang Y; Wu W; Selyutin O; Agrawal S; Feld B; Huang HC; Li C; Cheng KC; Shih NY; Kozlowski JA; Rosenblum SB; Njoroge FG
J Med Chem; 2012 Jan; 55(2):754-65. PubMed ID: 22148957
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase.
Harper S; Avolio S; Pacini B; Di Filippo M; Altamura S; Tomei L; Paonessa G; Di Marco S; Carfi A; Giuliano C; Padron J; Bonelli F; Migliaccio G; De Francesco R; Laufer R; Rowley M; Narjes F
J Med Chem; 2005 Jul; 48(14):4547-57. PubMed ID: 15999993
[TBL] [Abstract][Full Text] [Related]
6. Discovery of (7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymerase.
Narjes F; Crescenzi B; Ferrara M; Habermann J; Colarusso S; Ferreira Mdel R; Stansfield I; Mackay AC; Conte I; Ercolani C; Zaramella S; Palumbi MC; Meuleman P; Leroux-Roels G; Giuliano C; Fiore F; Di Marco S; Baiocco P; Koch U; Migliaccio G; Altamura S; Laufer R; De Francesco R; Rowley M
J Med Chem; 2011 Jan; 54(1):289-301. PubMed ID: 21141896
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.
Vandyck K; Cummings MD; Nyanguile O; Boutton CW; Vendeville S; McGowan D; Devogelaere B; Amssoms K; Last S; Rombauts K; Tahri A; Lory P; Hu L; Beauchamp DA; Simmen K; Raboisson P
J Med Chem; 2009 Jul; 52(14):4099-102. PubMed ID: 19507864
[TBL] [Abstract][Full Text] [Related]
8. Finger loop inhibitors of the HCV NS5b polymerase. Part II. Optimization of tetracyclic indole-based macrocycle leading to the discovery of TMC647055.
Vendeville S; Lin TI; Hu L; Tahri A; McGowan D; Cummings MD; Amssoms K; Canard M; Last S; Van den Steen I; Devogelaere B; Rouan MC; Vijgen L; Berke JM; Dehertogh P; Fransen E; Cleiren E; van der Helm L; Fanning G; Van Emelen K; Nyanguile O; Simmen K; Raboisson P
Bioorg Med Chem Lett; 2012 Jul; 22(13):4437-43. PubMed ID: 22633687
[TBL] [Abstract][Full Text] [Related]
9. Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase.
Habermann J; Capitò E; Ferreira Mdel R; Koch U; Narjes F
Bioorg Med Chem Lett; 2009 Feb; 19(3):633-8. PubMed ID: 19109015
[TBL] [Abstract][Full Text] [Related]
10. 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase.
McGowan D; Nyanguile O; Cummings MD; Vendeville S; Vandyck K; Van den Broeck W; Boutton CW; De Bondt H; Quirynen L; Amssoms K; Bonfanti JF; Last S; Rombauts K; Tahri A; Hu L; Delouvroy F; Vermeiren K; Vandercruyssen G; Van der Helm L; Cleiren E; Mostmans W; Lory P; Pille G; Van Emelen K; Fanning G; Pauwels F; Lin TI; Simmen K; Raboisson P
Bioorg Med Chem Lett; 2009 May; 19(9):2492-6. PubMed ID: 19342234
[TBL] [Abstract][Full Text] [Related]
11. The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
LaPorte MG; Draper TL; Miller LE; Blackledge CW; Leister LK; Amparo E; Hussey AR; Young DC; Chunduru SK; Benetatos CA; Rhodes G; Gopalsamy A; Herbertz T; Burns CJ; Condon SM
Bioorg Med Chem Lett; 2010 May; 20(9):2968-73. PubMed ID: 20347591
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent macrocyclic HCV NS5A inhibitors.
Yu W; Vibulbhan B; Rosenblum SB; Martin GS; Vellekoop AS; Holst CL; Coburn CA; Wong M; Selyutin O; Ji T; Zhong B; Hu B; Chen L; Dwyer MP; Jiang Y; Nair AG; Tong L; Zeng Q; Agrawal S; Carr D; Rokosz L; Liu R; Curry S; McMonagle P; Ingravallo P; Lahser F; Asante-Appiah E; Fells J; Kozlowski JA
Bioorg Med Chem Lett; 2016 Aug; 26(15):3793-9. PubMed ID: 27282743
[TBL] [Abstract][Full Text] [Related]
13. Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109.
Hirashima S; Suzuki T; Ishida T; Noji S; Yata S; Ando I; Komatsu M; Ikeda S; Hashimoto H
J Med Chem; 2006 Jul; 49(15):4721-36. PubMed ID: 16854079
[TBL] [Abstract][Full Text] [Related]
14. Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site.
Gopalsamy A; Chopra R; Lim K; Ciszewski G; Shi M; Curran KJ; Sukits SF; Svenson K; Bard J; Ellingboe JW; Agarwal A; Krishnamurthy G; Howe AY; Orlowski M; Feld B; O'Connell J; Mansour TS
J Med Chem; 2006 Jun; 49(11):3052-5. PubMed ID: 16722622
[TBL] [Abstract][Full Text] [Related]
15. Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors.
Ontoria JM; Rydberg EH; Di Marco S; Tomei L; Attenni B; Malancona S; Martin Hernando JI; Gennari N; Koch U; Narjes F; Rowley M; Summa V; Carroll SS; Olsen DB; De Francesco R; Altamura S; Migliaccio G; Carfì A
J Med Chem; 2009 Aug; 52(16):5217-27. PubMed ID: 19877603
[TBL] [Abstract][Full Text] [Related]
16. Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: discovery of deleobuvir (BI 207127).
LaPlante SR; Bös M; Brochu C; Chabot C; Coulombe R; Gillard JR; Jakalian A; Poirier M; Rancourt J; Stammers T; Thavonekham B; Beaulieu PL; Kukolj G; Tsantrizos YS
J Med Chem; 2014 Mar; 57(5):1845-54. PubMed ID: 24159919
[TBL] [Abstract][Full Text] [Related]
17. A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitors.
Chen KX; Lesburg CA; Vibulbhan B; Yang W; Chan TY; Venkatraman S; Velazquez F; Zeng Q; Bennett F; Anilkumar GN; Duca J; Jiang Y; Pinto P; Wang L; Huang Y; Selyutin O; Gavalas S; Pu H; Agrawal S; Feld B; Huang HC; Li C; Cheng KC; Shih NY; Kozlowski JA; Rosenblum SB; Njoroge FG
J Med Chem; 2012 Mar; 55(5):2089-101. PubMed ID: 22247956
[TBL] [Abstract][Full Text] [Related]
18. The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase.
Jackson RW; LaPorte MG; Herbertz T; Draper TL; Gaboury JA; Rippin SR; Patel R; Chunduru SK; Benetatos CA; Young DC; Burns CJ; Condon SM
Bioorg Med Chem Lett; 2011 Jun; 21(11):3227-31. PubMed ID: 21550237
[TBL] [Abstract][Full Text] [Related]
19. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
[TBL] [Abstract][Full Text] [Related]
20. 3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase.
Kumar DV; Rai R; Brameld KA; Riggs J; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Hu H; Lehoux I; Ho JD; Young WB; Hart B; Green MJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):300-4. PubMed ID: 22119470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
